Exact FDA event identifier

Event 79799

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: April 10, 2018
Product types: Drug
Classifications: Class III
Statuses: Terminated
Recalling firm wording: Pharmedium Services, LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Vasopressin 50 Units added to 250 mL 0.9% Sodium Chloride Injection USP (0.2 units per mL), Rx only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478

D-0632-2018

Recall number: D-0632-2018
Initiated: April 10, 2018
Classification: Class III
Status: Terminated
Recalling firm: Pharmedium Services, LLC
Quantity: 72 bags

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

cGMP deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP deviations

Code information

Lot: 180660057S Exp. 6/5/2018

Distribution pattern

MA, WA